Multiple sclerosis: advances in understanding, diagnosing, and treating the underlying disease
- PMID: 16444920
- DOI: 10.3949/ccjm.73.1.91
Multiple sclerosis: advances in understanding, diagnosing, and treating the underlying disease
Abstract
Recent advances in our understanding of the diagnosis, imaging, pathology, and clinical monitoring of multiple sclerosis (MS) have significantly increased our ability to successfully treat this often perplexing neurologic disorder. Magnetic resonance imaging (MRI) is now integral to the diagnostic process. Treatment of MS can be considered as three parallel pathways: treatment of relapses, symptom management, and long-term prevention of tissue injury.
Similar articles
-
[Recent advances in the pathogenesis and immunotherapy of multiple sclerosis].Nervenarzt. 2007 Sep;78 Suppl 1:15-24; quiz 25. doi: 10.1007/s00115-007-2327-8. Nervenarzt. 2007. PMID: 17668159 German.
-
[Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006)].Nervenarzt. 2006 Dec;77(12):1506-18. doi: 10.1007/s00115-006-2220-x. Nervenarzt. 2006. PMID: 17136556 German.
-
Benign multiple sclerosis: a distinct clinical entity with therapeutic implications.Curr Top Microbiol Immunol. 2008;318:1-17. doi: 10.1007/978-3-540-73677-6_1. Curr Top Microbiol Immunol. 2008. PMID: 18219812 Review.
-
Current approved options for treating patients with multiple sclerosis.Neurology. 2004 Dec 28;63(12 Suppl 6):S8-14. doi: 10.1212/wnl.63.12_suppl_6.s8. Neurology. 2004. PMID: 15623672 Review.
-
[Choice of early and escalation treatment options for multiple sclerosis].Nervenarzt. 2008 Oct;79(10):1123-4,1126-8,1130-2 passim. doi: 10.1007/s00115-008-2521-3. Nervenarzt. 2008. PMID: 18806985 Review. German.
Cited by
-
Can tetracyclines ensure help in multiple sclerosis immunotherapy?J Clin Transl Res. 2021 Feb 3;7(1):22-33. eCollection 2021 Feb 25. J Clin Transl Res. 2021. PMID: 34104806 Free PMC article. Review.
-
Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ).J Med Internet Res. 2011 Jan 24;13(1):e12. doi: 10.2196/jmir.1687. J Med Internet Res. 2011. PMID: 21266318 Free PMC article.
-
Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis.J Manag Care Spec Pharm. 2015 Aug;21(8):650-60. doi: 10.18553/jmcp.2015.21.8.650. J Manag Care Spec Pharm. 2015. PMID: 26233537 Free PMC article.
-
Soft Null Hypotheses: A Case Study of Image Enhancement Detection in Brain Lesions.J Comput Graph Stat. 2016;25(2):570-588. doi: 10.1080/10618600.2015.1023396. Epub 2016 May 10. J Comput Graph Stat. 2016. PMID: 30662249 Free PMC article.
-
Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making.Mol Diagn Ther. 2009;13(4):225-44. doi: 10.1007/BF03256329. Mol Diagn Ther. 2009. PMID: 19712003 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical